EAST RUTHERFORD, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that third quarter 2016 financial results will be released on Friday, November 4, 2016 before the market opens.

The Company will host a conference call to discuss the financial results.

 Third Quarter 2016 Earnings Conference Call 
   
When:Friday, November 4, 2016 at 8:30 a.m. Eastern Time
  
Dial-in:1-888-262-8770 for U.S.  
 1-913-312-1227 for International
 Passcode:  2914880 
   
Dial-in Replay: 1-888-203-1112 for U.S. 
 1-719-457-0820 for International
 Passcode:  2914880 
 Available through Friday, November 11, 2016
  
Webcast:  www.cambrex.com 
   

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances.  For more information, please visit www.cambrex.com.

Contact:
Stephanie LaFiura                                                                               
Investor Relations Associate                                                              
Tel: 201-804-3037                                                       
Email: stephanie.lafiura@cambrex.com       

Primary Logo